ACC Compensates $9.6m for Injuries Caused by COVID-19 – EVOL

A recent report reveals that the Accident Compensation Corporation (ACC) in New Zealand has paid out over $9.6 million to 1,664 individuals who were injured by the COVID-19 vaccine. These injuries include various reactions such as allergic reactions, sprains, cardiac injury, contusion, adverse drug reactions, anaphylactic reactions, infections, shoulder damage, cellulitis, bursitis, inflammation, and nerve damage.

The data covers the period from February 18, 2021, when vaccinations began in New Zealand, to April 6, 2024. Out of the 4,156 claims filed with the ACC, 1,664 were accepted, 2,440 were declined, and 52 remain undecided. As of April 9, 2024, 504 accepted claims resulted in payments exceeding $500, while 253 accepted claims had not received payments by the same date.

The payment breakdowns show that claimants received varying amounts, with 182 receiving between $1,000 to $5,000, 140 receiving between $500 to $1,000, over 500 receiving between $100 to $500, and 57 receiving between $5,000 to $10,000. Notably, there were 178 accepted claims related to cardiac injuries.

Although the specific vaccine administered was not always identified in the claims, the majority of injuries were linked to the Pfizer-BioNTech Comirnaty vaccine due to its prevalent use in the national vaccination program. The



Subscribe to Our Free Newsletter